MedTrace Logo

Topical "Non-Aromatic Very Rich in Steranes" (NAVS) Naphthalan for the Treatment of Oral Mucosal Diseases

NCT02920658 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 57

Last updated 2016-09-30

No results posted yet for this study

Summary

This study evaluates the effectiveness of topical NAVS naphthalan in the treatment of oral lichen planus (OLP) and recurrent aphthous stomatitis (RAS). Half of participants with OLP and RAS will receive topical NAVS naphthalan in adhesive paste, while the other half will receive 0.05%-betamethasone dipropionate in adhesive paste. Our hypothesis is that NAVS could be efficient in the treatment of OLP and RAS, with effects comparable to that of topical steroids.

Conditions

  • Oral Lichen Planus
  • Recurrent Aphthous Stomatitis

Interventions

DRUG

NAVS Naphthalan

DRUG

0.05% Betamethasone dipropionate

Sponsors & Collaborators

  • Ministry of Science, Education and Sport, Republic of Croatia

    collaborator OTHER_GOV

  • Ivan Alajbeg

    lead OTHER

Principal Investigators

  • Ivan Alajbeg, PhD · University of Zagreb

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-12-31
Primary Completion
2013-11-30
Completion
2013-11-30

Countries

  • Croatia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02920658 on ClinicalTrials.gov